FDA Approved: PRASUGREL — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved a supplemental application for the generic prasugrel from Accord Healthcare Inc., finalizing a regulatory action under the ANDA pathway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Ischemic Heart Disease

Drugs mentioned

• PRASUGREL (prasugrel)

Snippet

SUPPL AP for PRASUGREL (PRASUGREL)